--2026/Q4-- / 22.609M--
--2026/Q3-- / 21.550M--
--2026/Q220.731M / 22.325M--
--2026/Q117.699M / 17.450M--
--2025/Q445.891M / 50.704M--
US Stock MarketDetailed Quotes
Theravance Biopharma (TBPH)
- 17.080
- 0.0000.00%
Close Sep 4 15:59 ET
- 17.080
- 0.0000.00%
Post 16:10 ET
886.77MMarket Cap16.42P/E (TTM)
17.255High17.070Low160.55KVolume17.255Open17.080Prev Close2.74MTurnover0.62%Turnover Ratio8.29P/E (Static)51.92MShares21.03052wk High3.06P/B441.64MFloat Cap13.08052wk Low--Dividend TTM25.86MShs Float124.866Highest--Div Yield TTM1.08%Range %6.100Lowest17.080Avg Price1Lot Size
Theravance Biopharma (TBPH) Earnings Dates, Reports & Conference Call
TBPH 2026 Q2 Earnings Dates & Summary
Currency：USD--
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 22.33M | 20.73M | -1.59M |
| Miss Est. | -14.77% | -20.86% | -7.14% |
| Net Income | 4.02M | -5.90M | -9.92M |
| Miss Est. | -92.66% | -110.76% | -246.59% |
Analyst Rating
Sep 5, 2026
TBPH Revenue, EPS and EBIT Estimates
Revenue
Net Profit
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
TBPH Historical Earnings Dates & Reports
Read more